GROWTH OPPORTUNITIES IN VACCINES, GENE THERAPY, AND STEM CELL THERAPY

GROWTH OPPORTUNITIES IN VACCINES, GENE THERAPY, AND STEM CELL THERAPY

RELEASE DATE
23-Apr-2021
REGION
Global
Research Code: D759-00-1F-00-00
SKU: HC03408-GL-TA_25392

$950.00

Special Price $855.00 save 10 %

In stock
SKU
HC03408-GL-TA_25392

$950.00

$855.00 save 10 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) discusses multiple developments in vaccine technologies, both prophylactic and therapeutic. Most of the innovations highlighted are around influenza, COVID-19, and cancer vaccines. Developments in intranasal delivery, needle-free delivery, and thermostable formulations are also covered. Advanced technology platforms for scalable manufacturing and plug and play solutions, which can be applied to multiple pathogen serotypes are also discussed. Further, innovations in emerging technologies such as gene therapy for retinal diseases, immunotherapy for cancers, developments in nutraceuticals for cardiovascular protection and cosmeceuticals for skin and hair care and protein-based sweeteners are also profiled in this TOE.

The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms.

The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Vaccines, age-related macular degeneration, retinal diseases, mRNA vaccines, personalized vaccines, adenoviral vector vaccines, influenza vaccines, cardiovascular supplement, Arjuna supplement, nutraceuticals, immunotherapy, intranasal vaccine, needle-free vaccines, HIV vaccines, COVID-19 vaccines, thermostable vaccine, gene therapy, stem cell therapy, hearing loss, cervical cancer, breast cancer, ovarian cancer

Table of Contents

INNOVATIONS IN LIFE SCIENCES, HEALTH & WELLNESS

  • ALTIMMUNE, US
  • SERUM INSTITUTE OF INDIA PVT. LTD., INDIA
  • NOUSCOM, SWITZERLAND
  • VAXART, US
  • GPN VACCCINEs, AUSTRALIA
  • PROVIDENCE THERAPEUTICS, CANADA
  • 2A PHARMA APS, DENMARK
  • VACCITECH, UK
  • AFFINIVAX, US
  • MINERVAX, DENMARK
  • CODAGENIX, US
  • VAXXAS INC., US
  • GRADALIS INC., US
  • GOTHAM THERAPEUTICS CORPORATION, US
  • FLAVEX NATUREXTRAKTE GMBH, GERMANY
  • ENOVATE BIOLIFE, INDIA
  • GYROSCOPE THERAPEUTICS, UK
  • RINRI THERAPEUTICS, UK
  • BHARAT BIOTECH INTERNATIONAL LIMITED, INDIA
  • SANARIA INC., US
  • INTERNATIONAL AIDS VACCINE INITIATIVE, US
  • UNIVERSITY OF CONNECTICUT, US
  • ZICCUM AB, SWEDEN
  • GENNOVA, INDIA
  • Key Contacts
  • Key Contacts (CONTINUED)
  • Key Contacts (CONTINUED)
  • KEY CONTACTS (CONTINUED)
  • KEY CONTACTS (CONTINUED)
  • Key Contacts (CONTINUED)
Related Research
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) discusses multiple developments in vaccine technologies, both prophylactic and therapeutic. Most of the innovations highlighted are around influenza, COVID-19, and cancer vaccines. Developments in intranasal delivery, needle-free delivery, and thermostable formulations are also covered. Advanced technology platforms for scalable manufacturing and plug and play solutions, which can be applied to multiple pathogen serotypes are also discussed. Further, innovations in emerging technologies such as gene therapy for retinal diseases, immunotherapy for cancers, developments in nutraceuticals for cardiovascular protection and cosmeceuticals for skin and hair care and protein-based sweeteners are also profiled in this TOE. The Life Science, Health & Wellness TOE will feature disruptive technology advances in the global life sciences industry. The technologies and innovations profiled will encompass developments across genetic engineering, drug discovery and development, biomarkers, tissue engineering, synthetic biology, microbiome, disease management, as well as health and wellness among several other platforms. The Health & Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare. Keywords: Vaccines, age-related macular degeneration, retinal diseases, mRNA vaccines, personalized vaccines, adenoviral vector vaccines, influenza vaccines, cardiovascular supplement, Arjuna supplement, nutraceuticals, immunotherapy, intranasal vaccine, needle-free vaccines, HIV vaccines, COVID-19 vaccines, thermostable vaccine, gene therapy, stem cell therapy, hearing loss, cervical cancer, breast cancer, ovarian cancer
More Information
No Index No
Podcast No
Industries Healthcare
WIP Number D759-00-1F-00-00
Is Prebook No
Ti Codes D759